Table: Mochida Pharm -2022/23 group results

Mochida Pharmaceutical

15/05/2023 06:00

May 15 (Reuters)- 
          Mochida Pharmaceutical Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Mar 31, 2023    Mar 31, 2022   Mar 31, 2024     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales          103.26          110.18         104.00                 
               (-6.3 pct)      (+7.0 pct)     (+0.7 pct)               
  Operating        8.51           14.39           8.50                 
               (-40.9 pct)     (+19.9 pct)    (-0.1 pct)               
  Recurring        9.09           14.80           8.70                 
               (-38.6 pct)     (+20.7 pct)    (-4.2 pct)               
  Net
  Net              6.65           10.57           6.30                 
               (-37.1 pct)     (+23.1 pct)    (-5.3 pct)               
  EPS          178.93 yen      277.39 yen     172.45 yen               
  Ann Div       80.00 yen       90.00 yen      80.00 yen               
  -Q2 Div       40.00 yen       40.00 yen      40.00 yen               
  -Q4 Div       40.00 yen       50.00 yen      40.00 yen               
  
  NOTE - Mochida Pharmaceutical Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4534.T